Similar expression patterns were seen with SIINFEKL-activated OT-1 CD8 + T cells following treatment with Vidu/αQβ, although changes in PD-1 did not reach statistical significance due to high expression by all cells in response to SIINFEKL stimulation (Supplementary Fig.
← all excerpts
Intratumoral Virus-Like Particles Containing a TLR9 Agonist Combined with Systemic αPD-1 Activate Tumor-Specific CD8+ T Cells.
1
—
—